dalteparin has been researched along with Aphasia in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Aphasia: A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Karapurkar, AP | 1 |
Singh, R | 1 |
Teelala, SM | 1 |
Lalla, R | 1 |
Lui, JK | 1 |
McIntosh, LJ | 1 |
Escobar Valle, J | 1 |
Stockl, T | 1 |
Summers, S | 1 |
2 other studies available for dalteparin and Aphasia
Article | Year |
---|---|
Free-floating thrombus in a stenotic supraclinoid left internal carotid artery.
Topics: Aged; Anticoagulants; Aphasia; Carotid Artery, Internal; Carotid Stenosis; Enoxaparin; Female; Human | 2016 |
Facial Drooping, Aphasia, and an Incidental Lung Mass in a Nonsmoker.
Topics: Aged; Air Pollutants, Occupational; Anticoagulants; Aphasia; Atrial Flutter; Carcinoma, Squamous Cel | 2017 |